- Antibodies Against Specific MUC16 Glycosylation Sites Inhibit Ovarian Cancer Growth. ACS chemical biology. 2017 In Process GET IT
- Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion. PloS one. 2015 Academic Article GET IT
Dual-fluorescence isogenic high-content screening for MUC16/CA125 selective agents.
Molecular cancer therapeutics.
Times cited: 3
Successful eradication of established peritoneal ovarian tumors in SCID-Beige mice following adoptive transfer of T cells genetically targeted to the MUC16 antigen.
Clinical cancer research : an official journal of the American Association for Cancer Research.
Times cited: 27